BASILEA PHARM.NA SF 1 revenue breakdown overview

BASILEA PHARM.NA SF 1 revenue for the last year amounted to 221.76 M EUR, the most of which — 221.81 M EUR — came from its highest performing source at the moment, Innovative Pharmaceutical Products, the year earlier bringing 169.63 M EUR. The greatest contribution to the revenue figure was made by Ireland — last year it brought BASILEA PHARM.NA SF 1 99.66 M EUR, and the year before that — 73.93 M EUR.